Trailing-twelve-month (TTM) revenue is $815.05 Million with a year-over-year growth of +19.47%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $196,503,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-30 |
| Q4 FY2025Period ended 2025-12-31 | $212,928,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-24 |
| Q1 FY2026Period ended 2026-03-31 | $192,108,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-05 |
| Q2 FY2026Period ended 2026-06-30 | $213,513,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-04 |
| TTM revenue | $815,052,000 |
Current P/S: $1,642,927,887 market capitalization ÷ $815,052,000 TTM revenue = 2.02x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T14:15:20.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $213.51M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T14:15:46.188Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| International Supply Agreement | $4M | $954,000 | $15,000 | N/A | N/A | N/A |
| Products And Services | N/A | $242M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20152015-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Non Us | N/A | $19M | N/A | N/A | N/A | N/A |
| Non-US | $71M | N/A |
$815.05M
$815.05 Million
+19.47%
vs. $682.22M a year ago (TTM)
+33.61%
5 Year compound annual growth rate
1 Year
+19.47%
3 Year
+24.55%
5 Year
+33.61%
10 Year
+16.40%
15 Year
+10.14%
20 Year
+13.83%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $764.15M | +$152.59M | +24.95% |
| 2024 | $611.56M | +$129.30M | +26.81% |
| 2023 | $482.26M | +$131.40M | +37.45% |
| 2022 | $350.87M | +$107.66M | +44.26% |
| 2021 | $243.21M | +$98.35M | +67.89% |
| 2020 |
TTM Growth
+19.47%
3-Year CAGR
+24.55%
5-Year CAGR
+33.61%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T14:15:46.188Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
| $482M |
| $612M |
| $764M |
| United States Product | $141M | N/A | N/A | N/A | N/A | N/A |
|---|
| $37M |
| $40M |
| $48M |
| UNITED STATES | $115M | $224M | $327M | $445M | $571M | $716M |
|---|
| $144.86M |
| +$31.43M |
| +27.71% |
| 2019 | $113.43M | +$21.73M | +23.70% |
| 2018 | $91.69M | ($10.04M) | (9.87%) |
| 2017 | $101.74M | ($18.51M) | (15.39%) |
| 2016 | $120.25M | ($65.03M) | (35.10%) |
